Key Developments: Cardica Inc (CRDC.OQ)

CRDC.OQ on NASDAQ Stock Exchange Global Market

1.20USD
10:31am EDT
Price Change (% chg)

$0.01 (+0.84%)
Prev Close
$1.19
Open
$1.21
Day's High
$1.21
Day's Low
$1.20
Volume
2,953
Avg. Vol
12,841
52-wk High
$1.96
52-wk Low
$0.67

Search Stocks

Latest Key Developments (Source: Significant Developments)

Cardica Inc Prices Public Offering Of Common Stock
Friday, 15 Mar 2013 08:55am EDT 

Cardica Inc announced the pricing of an underwritten public offering of 14,251,368 shares of common stock, offered at a price to the public of $1.05 per share. The gross proceeds to Cardica from this offering are expected to be $14.96 million, before deducting underwriting discounts and commissions and other estimated offering expenses payable by Cardica. The offering is expected to close on or about March 20, 2013. Cardica anticipates using the net proceeds from the offering for general corporate purposes, which may include the costs of research and development activities, and general and administrative and manufacturing expenses. Wedbush PacGrow Life Sciences is acting as sole manager for the offering.  Full Article

Cardica Inc Proposes Public Offering of Common Stock
Thursday, 14 Mar 2013 04:36pm EDT 

Cardica Inc announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering. There can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. Wedbush PacGrow Life Sciences is acting as sole manager for the offering.  Full Article

Cardica, Inc. Prices Public Offering Of Common Stock
Wednesday, 8 Feb 2012 08:30am EST 

Cardica, Inc. announced the pricing of an underwritten public offering of 9,091,000 shares of its common stock, offered at a price to the public of $1.65 per share. The gross proceeds to Cardica from this offering are expected to be $15 million, before deducting underwriting discounts and commissions and other estimated offering expenses payable by Cardica. The offering is expected to close on or about February 13, 2012, subject to customary closing conditions. Cardica anticipates using the net proceeds from the offering for general corporate purposes, which may include the costs of research and development activities, and general and administrative and manufacturing expenses. Wedbush PacGrow Life Sciences is acting as sole book-running manager for the offering.  Full Article

Cardica, Inc. Announces Proposed Public Offering Of Common Stock
Tuesday, 7 Feb 2012 04:07pm EST 

Cardica, Inc. announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering. There can be no assurance as to whether or when the offering may be completed, or as to the size or terms of the offering. Wedbush PacGrow Life Sciences is acting as sole book-running manager for the offering.  Full Article

Search Stocks